Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating is one of the most commonly reported experiences in the early weeks on Wegovy. Semaglutide slows the rate at which the stomach empties, and for many people that change produces a full, gassy, uncomfortable feeling that can last hours after eating. It tends to be most noticeable when treatment begins or after a dose step up, and for most people it eases as the body adjusts. These are prescription-only medicines, and a GPhC-registered prescriber will assess whether Wegovy is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy contains semaglutide, a GLP-1 receptor agonist. One of its core effects is slowing gastric emptying: food moves from the stomach into the small intestine more gradually than usual. That slowdown is part of how Wegovy reduces appetite, because a fuller stomach signals the brain to stop eating sooner. The trade-off is that gas, fluid and partially digested food sit in the digestive tract for longer, creating the tight, distended sensation most people recognise as bloating.
The effect is not uniform across the gut. Reduced movement in the large intestine can cause constipation, which adds to the pressure. Swallowed air (more common when people eat quickly or drink through straws) has fewer exits, so it accumulates. The NHS medicines page for semaglutide lists bloating, nausea, constipation and excess gas among the commonly reported effects, all connected to the same underlying change in gut motility.
Dose increases tend to restart the process. If you felt fine at 0.5 mg and then noticed bloating again at 1.0 mg, that pattern is typical: your digestive system is adjusting to a stronger signal. Many people find the bloating at each rung lasts one to three weeks before settling, though timings vary.
For a broader picture of how the medicine works and what the licensed treatment pathway looks like, the Wegovy overview page covers the full schedule and eligibility criteria.
Most bloating on Wegovy is uncomfortable but not dangerous. The decision most people need to make is whether what they are feeling is within the expected range or whether it is something their prescriber needs to hear about.
Ordinary Wegovy bloating tends to feel like general abdominal fullness, comes on after eating, eases over a few hours and is accompanied by burping or flatulence. It may be worse on some days than others, particularly after larger meals or foods high in fat or fibre.
A different picture warrants medical attention. In January 2026, the MHRA issued a Drug Safety Update noting that acute pancreatitis is a known, if infrequent, side effect of GLP-1 medicines: the key symptom is severe, persistent stomach pain that spreads to the back, sometimes with vomiting. That is not bloating. If you experience it, stop eating, do not take your next dose until you have spoken to a clinician, and seek urgent care. You can report unexpected side effects directly through the MHRA Yellow Card scheme.
Gallbladder-related pain is another signal to look for: sharp pain under the right ribcage, particularly after fatty food. Wegovy has been associated with gallstone formation, and this is distinct from generalised bloating.
If you are unsure which category your symptoms fall into, contact a clinician rather than waiting. At nume, our clinical team is available for aftercare seven days a week.
The good news is that the degree of bloating is partly within your control. None of these are guaranteed fixes, but the changes below consistently come up in clinical practice as helpful.
Eat slowly. Because gastric emptying is already slower, adding food faster than the stomach can process it amplifies discomfort significantly. Putting the fork down between bites sounds basic, but it makes a real difference. Smaller meals, eaten more frequently, also reduce the load on a stomach that is doing its job at half speed.
Consider what you are eating. Highly fermentable foods (onions, beans, cruciferous vegetables, carbonated drinks) produce more gas in any digestive system, and that effect is amplified when transit time is prolonged. That does not mean removing them entirely; it means timing them carefully and watching your response.
Keep the pen in the fridge door where you will see it, and pair the injection day with a lighter evening meal. Several people find that the 24 hours after their weekly dose are when bloating peaks, and planning around that rhythm helps.
Hydration matters more than most people expect. Constipation-driven bloating improves with consistent fluid intake throughout the day. If constipation itself is significant, speak to your prescriber before reaching for laxatives, as some interact with treatment or mask other symptoms.
For more targeted strategies, the guide to managing Wegovy bloating covers these and other approaches in detail. There is also a broader look at the pattern of bloating across the dose schedule for those who want to understand how symptoms typically change over time.
For a small number of people, bloating does not settle between doses. If you are still significantly uncomfortable after four to six weeks on a given dose, that is worth raising with your prescriber rather than enduring in silence. Occasionally the titration pace is the issue: moving up doses more slowly, where clinically appropriate, can reduce the severity of GI side effects without compromising the overall treatment benefit.
There is also the question of whether Wegovy is the right medicine for you at all. Some people find semaglutide's GI profile difficult to manage long-term, and if you are researching alternatives it is worth reading about Driada semaglutide to understand how different formulations compare. A prescriber can discuss whether the dose trajectory, the formulation or the medicine itself needs reviewing. The detailed page on this topic looks at when persistent symptoms justify a clinical conversation, including what to tell your prescriber to make that conversation productive.
Cost considerations sometimes come into the picture too, particularly if someone is weighing whether to continue private treatment. The Wegovy price comparison explains what private treatment typically includes and what the NHS route looks like, which can help frame that decision clearly.
If you are considering Wegovy for the first time, or want your current treatment reviewed properly, start your free consultation with our prescribers. Every application is read by a real clinician the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.